The membrane protein seizure 6–like (SEZ6L) is a neuronal substrate of the Alzheimer’s disease protease BACE1, and little is known about its physiological function in the nervous system. Here, we show that SEZ6L constitutive knockout mice display motor phenotypes in adulthood, including changes in gait and decreased motor coordination. Additionally, SEZ6L knockout mice displayed increased anxiety-like behaviour, although spatial learning and memory in the Morris water maze were normal. Analysis of the gross anatomy and proteome of the adult SEZ6L knockout cerebellum did not reveal any major differences compared to wild type, indicating that lack of SEZ6L in other regions of the nervous system may contribute to the phenotypes observed. In su...
Abstract. Introduction:. Seizure-related protein 6 (Sez6) contributes to chronic pain development as...
Alzheimer’s disease (AD) is the most common form of dementia clinically characterized by a significa...
SummaryΒACE1 is the major drug target for Alzheimer’s disease, but we know surprisingly little about...
Background: The protease BACE1 (beta-site APP cleaving enzyme) is a major drug target in Alzheimer’s...
© 2019 Amelia Nicole NashCorrect wiring of the brain during development is a complex process that in...
Seizure protein 6 (SEZ6) is required for the development and maintenance of the nervous system, is a...
BACKGROUND: Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is a promising drug target...
Seizure protein 6 (SEZ6) is required for the development and maintenance of the nervous system, is a...
It is intriguing that a rare, inherited lysosomal storage disorder Niemann-Pick type C (NPC) shares ...
Abstract BACE inhibitors, which decrease BACE1 (β-secretase 1) cleavage of the amyloid precursor pro...
It is intriguing that a rare, inherited lysosomal storage disorder Niemann-Pick type C (NPC) shares ...
The formation of amyloid-ß peptides (Aß), that accumulate in Alzheimer’s disease (AD) brains, involv...
SummaryBACE1 is the major drug target for Alzheimer's disease, but we know surprisingly little about...
<p>(A-C) Western blot analyses of soluble Sez6 (sSez6), soluble Sez6L (sSez6L), total soluble APP (s...
Introduction: Seizure-related protein 6 (Sez6) contributes to chronic pain development as sez6 knock...
Abstract. Introduction:. Seizure-related protein 6 (Sez6) contributes to chronic pain development as...
Alzheimer’s disease (AD) is the most common form of dementia clinically characterized by a significa...
SummaryΒACE1 is the major drug target for Alzheimer’s disease, but we know surprisingly little about...
Background: The protease BACE1 (beta-site APP cleaving enzyme) is a major drug target in Alzheimer’s...
© 2019 Amelia Nicole NashCorrect wiring of the brain during development is a complex process that in...
Seizure protein 6 (SEZ6) is required for the development and maintenance of the nervous system, is a...
BACKGROUND: Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is a promising drug target...
Seizure protein 6 (SEZ6) is required for the development and maintenance of the nervous system, is a...
It is intriguing that a rare, inherited lysosomal storage disorder Niemann-Pick type C (NPC) shares ...
Abstract BACE inhibitors, which decrease BACE1 (β-secretase 1) cleavage of the amyloid precursor pro...
It is intriguing that a rare, inherited lysosomal storage disorder Niemann-Pick type C (NPC) shares ...
The formation of amyloid-ß peptides (Aß), that accumulate in Alzheimer’s disease (AD) brains, involv...
SummaryBACE1 is the major drug target for Alzheimer's disease, but we know surprisingly little about...
<p>(A-C) Western blot analyses of soluble Sez6 (sSez6), soluble Sez6L (sSez6L), total soluble APP (s...
Introduction: Seizure-related protein 6 (Sez6) contributes to chronic pain development as sez6 knock...
Abstract. Introduction:. Seizure-related protein 6 (Sez6) contributes to chronic pain development as...
Alzheimer’s disease (AD) is the most common form of dementia clinically characterized by a significa...
SummaryΒACE1 is the major drug target for Alzheimer’s disease, but we know surprisingly little about...